Redline Lab Groupsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-02-10
Share capital
2,400,000.00 PLN
Registered address
ul. Odrzycka 17A, 60-186 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 765 days for 2022).

  • 2025not filed
  • 202418/08/2025
  • 202318/08/2025
  • 202218/08/2025
  • 202129/09/2022
  • 202030/06/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Scientific research and development1,552 / 1,952
Top 80%
Voivodeship · Wielkopolskie43,146 / 49,541
Top 87%
Country · Poland429,941 / 495,935
Top 87%

Results vs industry

Revenue
This companyUSD 3.91kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD -5.11kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 9.02kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 54.08kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Dominik Czyżage 49 – President of the Management Board

Manner of representation

If the management board is multi-member, declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
2,400$64,829.8210%
21,600$583,468.4090%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-10-29.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$762
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$8,975

Competitors

Name
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Relvosp. z o.o.
Microblicsp. z o.o.
Xenstatssp. z o.o.
Poltisssp. z o.o.
Omnisepticasp. z o.o.
Fungotechsp. z o.o.
Dystrogen TherapeuticsS.A.
MIMO BiotechP.S.A.

Change history

DateEvent
2021-11-19Name change
2021-11-19PKD change
2015-02-10Entered in the register

FAQ

Last updated: 2026-04-10